The 19th Annual Biomarkers Congress is dedicated to the latest integration of biomarkers in drug development through case studies by major pharma on multiple therapeutic areas, including immuno-oncology, neuroscience, NASH, and immunology.
Topics
- Genomic & Multi-Omic Approaches In Drug Discovery
- Biomarkers for Diagnostics & Precision Medicine
- Biomarkers for Clinical Development
- Digital Pathology & Imaging and AI For Biomarker Research
- New Emerging Biomarker Technologies
- Biomarkers: Identification & Validation in Oncology, Immuno-Oncology & Immunology
- Biomarkers: Identification & Validation in Neuroscience, NASH & Co-Morbidity
- Biomarkers For Clinical Trials & Precision Medicine
Who should Attend
- Researchers and professionals in drug development
- Clinical trial specialists
- Experts in diagnostics and precision medicine
- Scientists and professionals in biomarker research
- Individuals interested in digital pathology and imaging
- Those exploring AI applications in biomarker research
- Pharmaceutical professionals focusing on immuno-oncology, neuroscience, NASH, and immunology
- Anyone involved in early detection of cancer through biomarkers
